Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov study page continues to show a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of showing the study details. This indicates the record is currently inaccessible to users.SummaryDifference18%

- Check33 days agoChange DetectedThe site's software version was updated from v3.6.6 to v3.7.0. This marks a new release of the underlying platform and does not alter page content.SummaryDifference0.0%

- Check40 days agoChange DetectedTel Litwinsky, Israel was added as a collaborator on the study page. Rheumatoid arthritis and the MedlinePlus Genetics related topic, along with the Qiryat Krinitzi, Israel location, were removed from the page.SummaryDifference0.1%

- Check47 days agoChange DetectedA new study site in Qiryat Krinitzi, Israel was added and Tel Litwinsky, Israel was removed, altering the enrollment locations. The page revision was updated to v3.6.6, replacing the previous version.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded funding metadata (2016 U.S. NIH Grant/Contract) and a related topics reference (MedlinePlus Genetics). Reaffirmed the study’s core condition (rheumatoid arthritis).SummaryDifference0.1%

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.